Risk stratification in the primary care setting may not lead to significant improvements in pain or function for people with musculoskeletal disorders, but may have benefits for clinical decision-making, the UK-based STarT MSK trial shows.
Serotonin–noradrenaline reuptake inhibitors may reduce pain for up to 3 months in people with osteoarthritis, but it is unclear whether the effect is clinically relevant, show the results of a meta-analysis published in The BMJ.
David Sherry discusses various pharmacologic and non-pharmacologic treatments for management of pediatric fibromyalgia, and outlines the impact of an interdisciplinary approach on physical function, mental health and pain outcomes in these patients.
Results of a systematic review and meta-analysis suggest that a substantial proportion of patients with chronic inflammatory arthritis have concomitant fibromyalgia, which may influence measures of disease activity.
Keep up with podcasts on this topic, available on
Stay informed with Medicine Matters
Get the latest developments in rheumatology delivered straight to your inbox